Viktor Rognås

• Medarbetarportalen (log in)
• ORCiD

• Combining colistin and meropenem in critically ill patients

  https://www.youtube.com/watch?v=jrnQOBv5OPQ

  Part of the Uppsala Antibiotic Center (UAC) seminar series UAC: https://uac.uu.se

Hello! I'm currently working on my Ph.D. within Uppsala Antibiotic Center. Back in 2017, I got my master's in Chemical Engineering from Uppsala University. At the same time, I explored the world of business and got a diploma from the School of Entrepreneurship.

But it's not all about studies! I'm also part of the team working on Pharmpy, a software project for pharmacometrics. You can see what we're up to on GitHub.

Want to know more? Check out my personal website

I'm diving deep into the complex world of antibiotic drug development, specifically focusing on colistin, a powerful antibiotic. Inspired by the work of Dr John Rex and others in 2013, my goal is to make antibiotic drug development more feasible by designing efficient clinical trials.

I'm developing methods to analyze trial data more effectively, aiming to reduce the number of patients needed in studies, and incorporating pre-existing data to enhance our understanding of treatments for specific groups of patients.

Through a series of projects, I'm analyzing colistin's effects on critically ill patients, including its impact on kidney function and its efficacy against resistant bacteria. I'm also keen on utilizing modern, adaptive study designs to maximize the efficiency of clinical trials for antibiotic treatments, ultimately aiming to facilitate the development of new, effective drug combinations.